$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

$sbra Overview Financials Valuation SEC Filings Company Website

2012 Q1 Form 10-Q Financial Statement

#000149229812000025 Filed on May 08, 2012

Income Statement

Concept	2012 Q1	2011 Q1
Revenue	$23.73M	$17.60M
YoY Change	34.8%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.300M	$2.700M
YoY Change	59.26%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$7.303M	$6.086M
YoY Change	20.0%
% of Gross Profit
Operating Expenses	$11.60M	$8.800M
YoY Change	31.82%
Operating Profit
YoY Change
Interest Expense	-$7.700M	-$7.600M
YoY Change	1.32%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$4.400M	$1.200M
YoY Change	266.67%
Income Tax	$0.00	$0.00
% Of Pretax Income	0.0%	0.0%
Net Earnings	$4.405M	$1.248M
YoY Change	252.96%
Net Earnings / Revenue	18.57%	7.09%
Basic Earnings Per Share	$0.12	$0.05
Diluted Earnings Per Share	$0.12	$0.05
COMMON SHARES
Basic Shares Outstanding	37.04M shares	25.14M shares
Diluted Shares Outstanding	37.06M shares	25.21M shares

Balance Sheet

Concept	2012 Q1	2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.700M	$80.20M
YoY Change	-96.63%
Cash & Equivalents	$2.675M	$80.21M
Short-Term Investments
Other Short-Term Assets	$31.00M	$16.80M
YoY Change	84.52%
Inventory		$476.2M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$33.70M	$573.2M
YoY Change	-94.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$680.6M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$32.20M	$31.80M
YoY Change	1.26%
Total Long-Term Assets	$712.8M	$31.90M
YoY Change	2134.62%
TOTAL ASSETS
Total Short-Term Assets	$33.70M	$573.2M
Total Long-Term Assets	$712.8M	$31.90M
Total Assets	$746.5M	$605.1M
YoY Change	23.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.80M	$13.20M
YoY Change	34.85%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$43.30M	$39.50M
YoY Change	9.62%
LONG-TERM LIABILITIES
Long-Term Debt	$382.6M	$385.7M
YoY Change	-0.8%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$382.6M	$385.7M
YoY Change	-0.8%
TOTAL LIABILITIES
Total Short-Term Liabilities	$43.30M	$39.50M
Total Long-Term Liabilities	$382.6M	$385.7M
Total Liabilities	$425.9M	$425.1M
YoY Change	0.2%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$370.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$320.6M	$179.9M
YoY Change
Total Liabilities & Shareholders Equity	$746.5M	$605.1M
YoY Change	23.38%

Cashflow Statement

Concept	2012 Q1	2011 Q1
OPERATING ACTIVITIES
Net Income	$4.405M	$1.248M
YoY Change	252.96%
Depreciation, Depletion And Amortization	$7.303M	$6.086M
YoY Change	20.0%
Cash From Operating Activities	$16.46M	$12.46M
YoY Change	32.16%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$5.400M
YoY Change	-100.0%
Cash From Investing Activities	-$40.21M	-$5.415M
YoY Change	642.55%
FINANCING ACTIVITIES
Cash Dividend Paid	$12.21M	$0.00
YoY Change
Common Stock Issuance & Retirement, Net	-$370.0K	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$15.83M	-$1.066M
YoY Change	1384.99%
NET CHANGE
Cash From Operating Activities	$16.46M	$12.46M
Cash From Investing Activities	-$40.21M	-$5.415M
Cash From Financing Activities	-$15.83M	-$1.066M
Net Change In Cash	-$39.58M	$5.977M
YoY Change	-762.12%
FREE CASH FLOW
Cash From Operating Activities	$16.46M	$12.46M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	14139000	USD
CY2012Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	17804000	USD
CY2011Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	18791000	USD
CY2012Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	26599000	USD
CY2012Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	346827000	USD
CY2011Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	344995000	USD
CY2011Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1142000	USD
CY2012Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2203000	USD
CY2012Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-4000	USD
CY2011Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-4000	USD
CY2012Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	566000	USD
CY2011Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	495000	USD
CY2011Q4	us-gaap	Assets Assets	749650000	USD
CY2012Q1	us-gaap	Assets Assets	746545000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42250000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2675000	USD
CY2011Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80210000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74233000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-39575000	USD
CY2011Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5977000	USD
CY2012Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0
CY2012Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.33
CY2012Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2012Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36891712	shares
CY2012Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37009602	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36891712	shares
CY2012Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37009602	shares
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	369000	USD
CY2012Q1	us-gaap	Common Stock Value CommonStockValue	370000	USD
CY2012Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	25540000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	25540000	USD
CY2011Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6086000	USD
CY2012Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7303000	USD
CY2012Q1	us-gaap	Dividends Common Stock DividendsCommonStock	-12213000	USD
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2011Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2011Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2011Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2670000	USD
CY2012Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4321000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4053000	USD
CY2011Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4106000	USD
CY2011Q1	us-gaap	Increase Decrease In Deferred Rent Receivables IncreaseDecreaseInDeferredRentReceivables	0	USD
CY2012Q1	us-gaap	Increase Decrease In Deferred Rent Receivables IncreaseDecreaseInDeferredRentReceivables	969000	USD
CY2011Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-391000	USD
CY2012Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	126000	USD
CY2012Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	967000	USD
CY2011Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	1006000	USD
CY2011Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	7597000	USD
CY2012Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	7698000	USD
CY2011Q1	us-gaap	Interest Paid InterestPaid	2447000	USD
CY2012Q1	us-gaap	Interest Paid InterestPaid	2140000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	423077000	USD
CY2012Q1	us-gaap	Liabilities Liabilities	425947000	USD
CY2012Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	746545000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	749650000	USD
CY2011Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1066000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15830000	USD
CY2011Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5415000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40209000	USD
CY2011Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12458000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16464000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	4405000	USD
CY2011Q1	us-gaap	Net Income Loss NetIncomeLoss	1248000	USD
CY2011Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	17561000	USD
CY2012Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	23663000	USD
CY2011Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2012Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	12213000	USD
CY2011Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	306000	USD
CY2012Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2456000	USD
CY2011Q1	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	86000	USD
CY2012Q1	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	256000	USD
CY2011Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	5329000	USD
CY2012Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	USD
CY2012Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	29850000	USD
CY2011Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	0	USD
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-370000	USD
CY2011Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2012Q1	us-gaap	Proceeds From Loan Originations ProceedsFromLoanOriginations	10103000	USD
CY2011Q1	us-gaap	Proceeds From Loan Originations ProceedsFromLoanOriginations	0	USD
CY2011Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	108916	USD
CY2012Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	116166	USD
CY2012Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	680635000	USD
CY2011Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	658377000	USD
CY2011Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	760000	USD
CY2012Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	791000	USD
CY2012Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6664000	USD
CY2011Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6093000	USD
CY2012Q1	us-gaap	Revenues Revenues	23727000	USD
CY2011Q1	us-gaap	Revenues Revenues	17601000	USD
CY2012Q1	us-gaap	Secured Debt SecuredDebt	157603000	USD
CY2011Q4	us-gaap	Secured Debt SecuredDebt	158398000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2203000	USD
CY2011Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1142000	USD
CY2012Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-370000	USD
CY2011Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	326573000	USD
CY2012Q1	us-gaap	Stockholders Equity StockholdersEquity	320598000	USD
CY2011Q1	us-gaap	Stockholders Equity StockholdersEquity	179923000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	177533000	USD
CY2011Q4	us-gaap	Unsecured Debt UnsecuredDebt	225000000	USD
CY2012Q1	us-gaap	Unsecured Debt UnsecuredDebt	225000000	USD
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37058886	shares
CY2011Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25211585	shares
CY2011Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25136140	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37035970	shares
CY2011Q1	sbra	Interest Income InterestIncome	40000	USD
CY2012Q1	sbra	Interest Income InterestIncome	64000	USD
CY2012Q1	sbra	Liability For Uncertain Tax Positions LiabilityForUncertainTaxPositions	25540000	USD
CY2011Q4	sbra	Liability For Uncertain Tax Positions LiabilityForUncertainTaxPositions	25540000	USD
CY2011Q4	sbra	Prepaid Expenses Deferred Financing Costs And Other Assets PrepaidExpensesDeferredFinancingCostsAndOtherAssets	17390000	USD
CY2012Q1	sbra	Prepaid Expenses Deferred Financing Costs And Other Assets PrepaidExpensesDeferredFinancingCostsAndOtherAssets	31031000	USD
CY2011Q1	sbra	Total Expenses TotalExpenses	16353000	USD
CY2012Q1	sbra	Total Expenses TotalExpenses	19322000	USD
CY2012Q1	dei	Amendment Flag AmendmentFlag	false
CY2012Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2012Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2012Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
CY2012Q1	dei	Document Period End Date DocumentPeriodEndDate	2012-03-31
CY2012Q1	dei	Document Type DocumentType	10-Q
CY2012Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001492298
CY2012Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37051242	shares
CY2012Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2012Q1	dei	Entity Registrant Name EntityRegistrantName	Sabra Health Care REIT, Inc.

Files In Submission

Name	View Source	Status
0001492298-12-000025-index-headers.html	Edgar Link	pending
0001492298-12-000025-index.html	Edgar Link	pending
0001492298-12-000025.txt	Edgar Link	pending
0001492298-12-000025-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sbra-20120331.xml	Edgar Link	completed
sbra-20120331.xsd	Edgar Link	pending
sbra-20120331_cal.xml	Edgar Link	unprocessable
sbra-20120331_def.xml	Edgar Link	unprocessable
sbra-20120331_lab.xml	Edgar Link	unprocessable
sbra-20120331_pre.xml	Edgar Link	unprocessable
sbra10q033112.htm	Edgar Link	pending
sbraex101sabra_2012xbonusx.htm	Edgar Link	pending
sbraex102director_compensa.htm	Edgar Link	pending
sbraex121033112.htm	Edgar Link	pending
sbraex311033112.htm	Edgar Link	pending
sbraex312033112.htm	Edgar Link	pending
sbraex321033112.htm	Edgar Link	pending
sbraex322033112.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

2012 Q1 Form 10-Q Financial Statement

#000149229812000025 Filed on May 08, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA Sabra Health Care REIT, Inc. Stock $sbra

2012 Q1 Form 10-Q Financial Statement

#000149229812000025 Filed on May 08, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra